BONADONNA, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 9.189
AS - Asia 8.872
EU - Europa 5.438
SA - Sud America 1.223
AF - Africa 375
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 10
Totale 25.123
Nazione #
US - Stati Uniti d'America 8.958
SG - Singapore 3.487
CN - Cina 2.257
VN - Vietnam 1.389
SE - Svezia 983
IE - Irlanda 969
BR - Brasile 957
IT - Italia 824
HK - Hong Kong 721
UA - Ucraina 531
DE - Germania 450
FI - Finlandia 360
TR - Turchia 323
NL - Olanda 296
GB - Regno Unito 285
FR - Francia 283
ZA - Sudafrica 257
RU - Federazione Russa 157
CA - Canada 148
IN - India 132
AR - Argentina 96
BD - Bangladesh 79
IQ - Iraq 69
ES - Italia 51
AT - Austria 47
ID - Indonesia 45
JP - Giappone 44
MX - Messico 44
EC - Ecuador 41
PH - Filippine 39
PK - Pakistan 38
BE - Belgio 37
VE - Venezuela 35
CO - Colombia 32
KR - Corea 32
CZ - Repubblica Ceca 31
PL - Polonia 31
MA - Marocco 30
UZ - Uzbekistan 27
MY - Malesia 25
LT - Lituania 21
TH - Thailandia 19
CI - Costa d'Avorio 18
IR - Iran 18
RO - Romania 18
SA - Arabia Saudita 18
JO - Giordania 16
CL - Cile 15
EU - Europa 15
UY - Uruguay 15
PE - Perù 14
TN - Tunisia 14
KE - Kenya 13
AE - Emirati Arabi Uniti 12
TW - Taiwan 12
OM - Oman 10
PY - Paraguay 10
AZ - Azerbaigian 8
BO - Bolivia 8
IL - Israele 8
LB - Libano 8
PT - Portogallo 8
AU - Australia 7
BG - Bulgaria 7
DO - Repubblica Dominicana 7
HN - Honduras 7
AL - Albania 6
CR - Costa Rica 6
DK - Danimarca 6
EG - Egitto 6
ET - Etiopia 6
HU - Ungheria 6
NP - Nepal 6
RS - Serbia 6
GE - Georgia 5
GT - Guatemala 5
HR - Croazia 5
NG - Nigeria 5
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
CG - Congo 3
JM - Giamaica 3
ME - Montenegro 3
NI - Nicaragua 3
PA - Panama 3
SV - El Salvador 3
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
CM - Camerun 2
GA - Gabon 2
GR - Grecia 2
IM - Isola di Man 2
KW - Kuwait 2
LV - Lettonia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
Totale 25.090
Città #
Singapore 1.712
Chandler 1.077
Dublin 960
Ashburn 887
Dallas 795
San Jose 743
Hong Kong 655
Beijing 651
Jacksonville 498
Ho Chi Minh City 427
Boardman 423
Santa Clara 391
Ann Arbor 360
Hanoi 326
Parma 297
Izmir 265
Johannesburg 239
Nanjing 233
Lauterbourg 224
Princeton 218
Los Angeles 178
New York 172
Dearborn 157
Wilmington 156
Columbus 115
San Mateo 114
Shanghai 113
Moscow 111
The Dalles 110
Munich 92
Buffalo 89
São Paulo 86
Toronto 85
Hefei 74
Kunming 70
Nanchang 68
Woodbridge 63
Council Bluffs 61
Da Nang 55
Shenyang 55
Helsinki 52
Milan 52
Frankfurt am Main 51
Hebei 49
Guangzhou 44
Haiphong 43
Seattle 42
Jiaxing 41
Jinan 38
Changsha 35
Tianjin 34
Vienna 34
Chicago 32
Des Moines 32
Rio de Janeiro 32
Tokyo 31
Rome 30
Houston 29
Jakarta 29
Biên Hòa 28
Turku 28
Baghdad 27
London 27
Brooklyn 26
Falls Church 26
Montreal 26
Phoenix 25
Bremen 24
Brussels 24
Bologna 23
Curitiba 23
Nuremberg 23
Atlanta 22
Hải Dương 22
Tashkent 22
Warsaw 22
Norwalk 21
Amsterdam 19
Chennai 19
Zhengzhou 19
Abidjan 18
Belo Horizonte 18
Istanbul 18
Ninh Bình 18
Orem 18
Porto Alegre 17
Brno 16
Dong Ket 16
Hangzhou 16
Pune 16
Seoul 16
Stockholm 16
Amman 15
Boston 15
Piacenza 15
Quito 15
Brasília 14
Bến Tre 14
Can Tho 14
Mexico City 14
Totale 14.950
Nome #
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 257
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 232
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 232
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 214
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 213
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 212
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 206
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 204
Metabolomic Changes after Coffee Consumption: New Paths on the Block 204
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 203
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 196
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 195
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 190
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 184
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 184
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 180
Development and validation of an analytical hplc method to assess chemical and radiochemical purity of [68ga]ga-nodaga-exendin-4 produced by a fully automated method 178
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 173
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 170
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 162
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds 162
A compartmental model to quantitate in vivo glucose transport in the human forearm 161
Adipocytes IGFBP-2 expression in prepubertal obese children. 160
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycaemia and the risk of in-hospital mortality 160
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 156
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 156
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 156
Beta-cell function across the spectrum of glucose tolerance in obese youth. 155
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 151
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 148
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 147
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 146
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 146
Associations Between Pancreatic Lipids and β-Cell Function in Black African and White European Men With Type 2 Diabetes 145
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 142
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 142
Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics 142
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 141
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 141
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 141
How (poly)phenols can shape a healthier life? A nutri-omics investigation on their cardiometabolic health effects 140
Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults 139
Bariatric surgery or medical therapy for obesity 138
Nutri-omics: how omics investigation can help designing personalized nutrition research 137
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 136
Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells 135
Operation of Randle's cycle in patients with NIDDM 134
Pathogenesis of NIDDM. A balanced overview. 134
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 134
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: A 12-month randomized controlled trial in patients with type 2 diabetes 132
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19 128
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 127
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 126
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 126
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders 126
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 125
Obesity and insulin resistance in man. A dose response study 125
Time dependence of the interaction between lipid and glucose in humans 123
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 123
Predictors of insulin sensitivity in type 2 diabetes mellitus 121
Phasic insulin release and metabolic regulation in type 2 diabetes 120
Treatment intensification in patients with inadequate glycemic control on basal insulin: Rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 120
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 120
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health 118
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 118
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 117
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 117
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 117
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 116
Which is the eligible patient to be treated with pioglitazone? The expert view. 116
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score with Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study 116
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 115
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 114
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus 113
Evaluating endothelial function of the common carotid artery: An in vivo human model. 113
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 111
Estimation of organ transport function for recirculating indicator dilution curves 111
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 111
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange 111
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy 111
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 110
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 110
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 109
Fasting plasma glucose variability predicts 10-year survival of Type 2 diabetic patients. The Verona Diabetes Study 109
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 108
Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications 107
Metabolic interactions of amino acids and glucose in healthy humans 107
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 107
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 106
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 106
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 106
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 106
Metabolic and hemodynamic effects of insulin on human hearts 105
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 105
Muscle glucose transport and phosphorylation in type 2 diabetic, obese non-diabetic, and genetically predisposed individuals. 105
Effects of a new nutraceutical formulation (Berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: Results from a randomized, double blind, placebo-controlled study 105
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 104
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 103
Protein metabolism in human obesity: Relationship with glucose and lipid metabolism and with visceral adipose tissue. 103
Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion 102
Totale 14.024
Categoria #
all - tutte 91.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 76 205 107
2021/20221.084 92 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.399 90 136 66 50 113 334 72 96 40 49 146 207
2024/20254.754 79 302 336 311 583 341 127 278 617 503 409 868
2025/20269.593 733 1.097 1.264 661 1.485 550 1.374 468 1.292 669 0 0
Totale 25.589